HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 257 filers reported holding HAEMONETICS CORP in Q2 2019. The put-call ratio across all filers is 2.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $999,000 | +8.5% | 7,920 | +3.4% | 0.02% | +4.3% |
| Q2 2019 | $921,000 | +37.5% | 7,656 | 0.0% | 0.02% | +35.3% |
| Q1 2019 | $670,000 | -9.5% | 7,656 | +3.6% | 0.02% | -19.0% |
| Q4 2018 | $740,000 | -12.6% | 7,392 | 0.0% | 0.02% | +5.0% |
| Q3 2018 | $847,000 | +63.8% | 7,392 | +28.2% | 0.02% | +53.8% |
| Q2 2018 | $517,000 | +22.5% | 5,764 | 0.0% | 0.01% | +18.2% |
| Q1 2018 | $422,000 | +26.0% | 5,764 | 0.0% | 0.01% | +22.2% |
| Q4 2017 | $335,000 | +56.5% | 5,764 | +20.7% | 0.01% | +50.0% |
| Q3 2017 | $214,000 | +26.6% | 4,774 | +11.3% | 0.01% | +20.0% |
| Q2 2017 | $169,000 | +79.8% | 4,290 | +85.7% | 0.01% | +66.7% |
| Q1 2017 | $94,000 | +1.1% | 2,310 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $93,000 | – | 2,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |